Ligand validation:3S5Z

GAL: beta-D-galactopyranose

GAL is a Ligand Of Interest in 3S5Z designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3S5Z_GAL_B_803	46%	71%	0.159	0.893	0.47	0.64	-	-	0	0	100%	1
3S5Z_GAL_A_804	28%	72%	0.235	0.891	0.51	0.57	-	-	0	0	100%	1
1R47_GAL_A_1101	39%	72%	0.199	0.904	0.3	0.77	-	1	3	1	100%	1
3HG2_GAL_B_803	11%	57%	0.196	0.709	0.63	1	-	1	2	0	100%	1
3HG4_GAL_B_803	6%	60%	0.258	0.681	0.59	0.93	-	1	0	1	100%	1
4WWH_GAL_A_401	100%	64%	0.026	0.99	0.47	0.9	-	-	0	0	100%	1
5ELB_GAL_C_202	100%	58%	0.036	0.992	0.82	0.8	-	-	0	0	100%	0.6
3OGR_GAL_A_1024	99%	47%	0.053	0.987	0.79	1.26	-	1	1	0	100%	1
1NSX_GAL_B_2400	98%	50%	0.055	0.981	0.56	1.36	-	3	0	0	100%	1
4LKF_GAL_A_201	98%	55%	0.045	0.984	0.92	0.83	-	-	0	0	92%	0.9167

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.